What Is Androgenetic Alopecia, and Why Is It So Common in Men?
Androgenetic alopecia is a permanent hair loss driven by genetic sensitivity to DHT, where follicles gradually shrink over time — and it is far more common in men due to hormonal differences.
- Androgenetic alopecia is a chronic form of hair loss caused by inherited predisposition combined with follicle sensitivity to DHT, leading to gradual thinning and miniaturization.
- Its prevalence in men mainly comes down to genetics that shape androgen receptor density and how quickly testosterone converts to DHT.
- Diagnosis and staging rely on scalp examination and shedding history; treatment options vary depending on how advanced the hair loss is.
What Is Androgenetic Alopecia?
Androgenetic alopecia — widely known as male pattern hair loss — is the most common form of permanent hair loss worldwide. At its core is a gradual increase in the sensitivity of genetically predisposed follicles to androgen hormones, particularly dihydrotestosterone (DHT). This sensitivity shortens the anagen (growth) phase of the hair cycle while relatively extending the telogen (resting) phase; as a result, with each cycle the follicle becomes a little smaller, and produces a strand that is a little thinner and shorter.
This process is gradual, not sudden. A follicle does not disappear overnight; over years it undergoes a shrinking process called "miniaturization," eventually producing only a fine, barely visible hair or stopping production altogether. That's why androgenetic alopecia is usually first noticed as a slight recession at the hairline or subtle thinning at the crown, becoming more visible over time.
DHT and Follicular Miniaturization
Testosterone is converted into DHT in the body via the enzyme 5-alpha reductase. DHT binds to androgen receptors on follicles in the scalp — especially at the front hairline and crown — suppressing their growth signals. Interestingly, follicles at the back and sides of the same person's head are largely resistant to this effect, which is the scientific basis for using these areas as donor sites in hair transplantation. Sensitivity to DHT varies from person to person depending on androgen receptor density and genetic variation, which explains why two brothers of similar age can experience very different degrees of hair loss.
Why Is It So Common in Men?
Androgenetic alopecia also occurs in women, but it shows up markedly more often — and earlier — in men. The main reason is the difference in hormonal profile: circulating testosterone levels in men are far higher than in women, so the total amount converted into DHT is also greater. In addition, the distribution of androgen receptors across the male scalp is structured in a way that particularly favors shedding at the front hairline and crown.
Genetic Predisposition and Inheritance
Androgenetic alopecia follows a polygenic inheritance pattern — meaning predisposition arises from the combination of multiple genes rather than a single "baldness gene." Genetic material from both the mother's and father's side plays a role, which means the common belief that "hair loss is only inherited from the mother's side" is medically incomplete. A family history of early, pronounced hair loss increases the likelihood that a person will follow a similar course, but it isn't a hard rule — significant differences can appear even between siblings in the same family.
The age at which androgenetic alopecia begins also varies widely from person to person. In some men, recession at the hairline becomes noticeable in their early twenties, while in others visible thinning may not appear until their forties. Progression isn't linear either — it can speed up during some periods and remain relatively stable during others. Factors like stress, sleep patterns, and general health don't trigger the androgenetic process itself, but they can influence how quickly the existing process is perceived and how the scalp looks overall.
Staging with the Norwood Scale
In men, the extent and progression of androgenetic alopecia is classified clinically using the Norwood-Hamilton scale. This scale defines different stages, ranging from early hairline recession to a widening bald area at the crown. In early stages (slight hairline recession, fine thinning at the crown), protective and supportive approaches are generally favored, while in more advanced stages (a pronounced bald area that merges with the donor zone), hair transplant evaluation becomes relevant. Which approach fits which stage becomes clear through an assessment of the scalp and donor area — this evaluation is the core purpose of a hair analysis.
A Different Pattern in Women
In women, androgenetic hair loss generally follows a different pattern than the Norwood scale describes: the hairline is largely preserved while diffuse thinning appears at the crown. Because of this different course, a separate classification system (Ludwig) is used for female patients, and the evaluation process also involves ruling out other hormonal factors, such as thyroid conditions, PCOS, and menopause.
Diagnosis and Evaluation Process
A diagnosis of androgenetic alopecia is made based on shedding history, a family history of similar cases, and dermoscopic examination of the scalp. This examination assesses follicular diversity (a mix of thick and thin strands), the degree of miniaturization, and the condition of the donor area. The evaluation also aims to distinguish whether the hair loss is androgenetic or related to a temporary cause such as telogen effluvium, since the treatment approach differs completely depending on this distinction.
What Are the Treatment Options?
Because androgenetic alopecia is a progressive process, catching it early expands the range of options. In the early stages, supportive approaches — treatments that nourish the scalp, along with regular follow-up — may be preferred. Medication-based approaches (finasteride, minoxidil) are products that require a prescription or medical supervision; anyone considering this kind of treatment should consult a physician first to determine whether it suits their health history. In cases where some follicular activity remains, PRP treatment may be considered as a supportive option.
In cases where the hair loss has become permanent and resulted in a noticeable bald area, and the donor region has sufficient density, surgical methods such as FUE hair transplant come into consideration. The most reliable way to determine which stage someone is at, and which approach would be meaningful, is through a scalp and donor area evaluation.
Understanding androgenetic alopecia makes it easier for someone noticing hair loss to move toward an informed evaluation process rather than panic. Anyone who wants to learn how the process typically unfolds, and which options might suit their own situation, can get personalized information through a scalp evaluation.
Three photos are enough
Send three photos — front, crown and back. You'll receive your donor capacity, graft range and suitable technique within 24 hours.
Request a free analysisRelated articles
Finasteride and Minoxidil: What They Do and Don't Do
An informational look at how finasteride and minoxidil work, their limits, and their relationship with hair transplantation — and why a physician's evaluation matters before starting either one.
Iron, Vitamin D, and Ferritin: Their Role in Hair Loss
Hair follicles react to iron, ferritin, and vitamin D deficiencies earlier than most other tissues in the body; this article looks at how these deficiencies relate to shedding and evaluation.
Telogen Effluvium: Is Stress-Related Hair Loss Permanent?
Telogen effluvium occurs when more follicles than usual enter the resting phase at once, usually triggered by stress or a physical event — and in most cases, it is temporary.